Fluralaner (Bravecto®) induces long-term mortality of Lutzomyia longipalpis after a blood meal in treated dogs
Fluralaner; Dogs; Lutzomyia longipalpis; Leishmania infantum; Spectroscopy; Chemometrics; Multivariate analysis.
Visceral leishmaniasis is a serious and chronic disease with a geographic spread in
Brazil due to the absence of a treatment that eliminates the parasite, ineffective control
measures, and diagnostic methods with low accuracy. The study aimed to evaluate
the systemic insecticidal activity of a single oral dose of fluralaner against Lutzomyia
longipalpis, as well as evaluate the mid-infrared as an alternative for Leishmania
infantum detection in canine serum samples. Mongrel dogs were recruited and
randomized into two groups, fluralaner (n = 4) and control (n = 4), and female
specimens of Lu. longipalpis were allowed to feed on all dogs before treatment, on day
one post-treatment, and then monthly until 1-year post-treatment. In addition,
attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR)
combined with multivariate analysis was employed to distinguish samples from dogs
infected with L. infantum in different clinical forms (n = 29) from healthy animals (n =
30). After data analysis, there was 100% mortality of Lu. longipalpis for up to five
months after treatment initiation. The efficacy of fluralaner ranged from 100% on day
1 to 68% at six months with a decrease to 1.4% at one-year post-treatment. ATR-FTIR
was efficient in differentiating samples from infected and uninfected dogs with 100%
sensitivity and specificity using the successive projections algorithm with linear
discriminant analysis (SPA-LDA), SPA with support vector machine (SPA-SVM), and
the genetic algorithm with LDA (GA-LDA). These satisfactory results suggest that
fluralaner may be used as a control strategy for VL in endemic areas, as well as
spectroscopy associated with multivariate analysis demonstrates its potential as an
alternative tool for the VL diagnosis in dogs.